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Twenty failed hUman liver allograft speci~ens obtained at the time of 
retransplantation procedures were studied using a panel of monoclonal 
antibodies (T11, T4, T8. NK, B1, OKM1. OKM5, Ia, DR). A clinicopathologic 
analysis was used to distinguish between graft f3ilures secondary to rejection 
(no.=10) and those due at least in part to other etiologies (no.=10). T 
lymphocytes constituted the major infiltrating cellular population in the liver 
of rejection cases but Significant nJmbers of B cells and monocytes/macrophages 
were present also. Following transplantation, but not before, the bile duct 
epith~liumI as well 3S portal and central vein and hepatic artery endotheliu~ 
express DR/Ia antigens. These structures are preferential targets of the 
rejection reaction. The selective destruction of bile ducts in livers 
undergoing rejection was ~anifested in these patients bY'striking elevations of 
serum ga~~a glutamyl transpeptidase (GGTP) activity, a marker of biliary 
epithelial damage. The induced expression of DR/Ia antigens on structures 
targeted for immune destruction may be an important event in the pPtho~~n~sis 
of liver allograft rejection. 
KEY WORDS: Rejection, Liver Allograft, Monoclonal Antibodies, DR/Ia antigens, 
bile ducts, ga~~a glutamyl transpeptid3se and e~dotheliu~K 
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The clinical diagnosis of rejection following liver transplantation is 
often one of exclusion. The pathologic interpretation of liver biopsy 
specimens obtained from graft recipients can be difficult (1). This diffic~lty 
in establishing a specific clinical diagnosis exists because the allograft is 
susceptible to a wide variety of ins~ltsK PreSently, no definitive criteria 
for hepatic rejection are available other than various clinical parameters 
which can be combined with characteristic pathologic changes in biopsy 
specimens (1,2). Therefore. in an attempt to clarify at least some of the 
immunopathologic chang~s associated with liver rejection, we analyzed 20 failed 
allograft specimens utilizing a panel of monoclonal antibodies specific for 
surface antigens on inflammatory cells and combined this an3lysis with the 
patients' clinical and laboratory data. The histopathologic changes found in 
many of these post-transplant liver speci~ens have been reviewed in detail 
elsewhere (1). 
MATERIALS AND METHODS 
Case selection: Livers removed at retransplantation were selected for this 
study because of the immediate availability of sufficient fresh tissue for 
analysis. Normal control liver tissue W3S obtained from two trauma c~s~s and 
from three biopsy specimens perfor~ej for the detection of metastatic 
carcinoma in which no t~~or was found. 
Tissue preparation: Fresh liver tissue blocks were prepared within one 
hOi.lr of the resection or biopsy, frozen in OCT co;npound (V'..lR, Pittsburgh, P.::I.) 
at _200 C in a cryostat and stored at _600 C until sectioning. 
fmmunop~roxidPse staining: ~onoclonP1 antibodies were purch~sed from 
Becton-Dickinson, Inc., Sunnyvale, CA: Leu 7. HLA-DR; Ortho mhar~aceutical 
Corp., Raritall, lJJ: lh~lK OKH5; and from Coulter Ele:::tro:1ics, Inc., Hi-31'?3h, 
FL: T11, T4. T8, B1 and 12. Tne chromogen, 3-3:nlno-9-ethylcarbazole (A£C), 
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specificities of the monoclonal antibodies used in this study are listed in 
Table 1. The blocks were equilibrated to _200 C over a thr~e hour period, 
sectioned at 8 microns, fixed in period~te-fysine-parPform~ldehyde (PLP) (3) 
for 30 seconds, washed in phosphate buffered saline (PBS), and incubated in 
MK1~ hydrogen peroxide to block endo~enous peroxid~se activity. Appropriate 
dilutions of the monoclonal antibodies (determined on hUman tonsil tissue) were 
applied to tha sections, incubated for 15 ~inutesI washed (PBS), then inc~bated 
with peroxidasz-conjugated rabbit anti-mouse im~unoglobulins (1:20 dilution) 
(Accurate Chemicals) for 15 minutes. Following washin3 in PBS, the sections 
were incubated with AEC for 10 minutes, 'washed, counterstained with hematoxylin 
and mounted with lnmu~omount (Shandon, pe~ickleyI Pa.) for microscopy. In 
negative controls monoclonal antibodies were omitted and secondary antibody 
alone was applied followed by the remainder of the procedure as outlined 
above. 
Microscopic Analysis: Serial histologic sections ~ach stained with a 
different monoclonal antibody were reviewed without knowledge of the patients' 
clinical course. All cases were evaluated in sequence for each monoclonal 
antibody and subjectively scored (on a scal~ from 0-4). The stained 
inflammatory cells (T11, T4, T8, B1, OKM1, NK) present in each serial section 
~ere compared. A score ~f ~l~ indicated tne num~cr of inflammatory cells W3S 
indistinguishable from controls, and ~4" the most intense infiltration by cells 
stainaj with a given monoclonal antibody when compared to all other cases. For 
eXdfJple, the infiltrate illustrated in Figure 1f positive for OKr11 was scored 
as ~4"K Evaluation of the presence of DR/la (Class II Major Histocompatibility 
Complex [MHC)) antigens ~as also scored on a scale from 0-4 based o~ the 
relative number of bile duct epith~lialI 3S well as h~patic artery and port)l 
vein e~dothelial cells which st2ined on a review of the entire s~ctionK A 
score of "4" injicataj all structures ex~min!d were st~inedK The patterns of 
the inflammP~ory cell infiltration and the localization of any particular 
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Clinical analysis:· Information on the clinical course prior to 
retransplantation was obtained from a review of the ch3rts with special 
attention focused on the In::my possible etiologies for graft dysfunction other 
than rejection. The results of all investigative studies of biliary tract 
patency, blood and bile, bacterial, fung31 and viral c~ltur~sI cyclosporin 
levels, hepatitis serologies as well as clinical impressions were recorded. 
Maintainance immunosuppressive therapy in these patients consisted of 
cyclosporin 3nd steroids. Response to bolstered immunosuppression of the 
events occurrin~ im~ediately prior to resection were not taken into account, 
since the definitive therapy in these cases was 31lograft resection with 
retranspla~tationK 
Clinicopdthologic Analysis: A final diagnosis was derived after a review 
of both the clinic~l course and pathologic speoimen. All C3ses in which graft 
failure could be, at least partially, attributable to causes other than 
rejection (group B, see Results) were separated fro~ t~ose in which rejection 
was the only apparent cause for the graft failure (group A, sea Results). The 
patients in group A had no evidence of biliary tract obstruction, negative 
viral hepatitis B serologic tests, negative blood and bile cultures (when 
avai13ble) and a clinical diagnosis ~f rejection. 
RESULTS 
Tissue Distribution of Cellular Subsets 
kor~P1 Control Tissue 
In normal liver tissue a s:nall n'Jnber of cells positive for Tl1, T4, T8, 
lh~l and Bl antigens wer~ found mainly in the interstitium of the portal tr3cts 
anj occ3sionally in t!1e sinusoidal lUl1ens. A si:nllar distribution of 
infla~~atory cells in nor~al liver tissue h3S been d~scrib~d previously (4). 
a~/fa stl~DiD~ ~1P c~~Pistently S0en in cells lining the pi~rRMidsK 3nd ~n 
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the portal tra~ts in dendriti~ cells and in endothelial cells of small 
capillary-sized vascular channels. These dendritic cells and small capillaries 
were often in close 3ssociation with bile ductules. Kupffer cells could not be 
reliably differentiated froffi endothelial cells within the sinusoids. Focal 
st3ining of central and portal vein endothelial cells was occasionally seen but 
the majority of these cells did not stain. Biliary epithelial cells were 
negative fur DR/la antigens. 
Toe staining pattern with OKM5 W3S very similar to that seen for the DR/la 
antigens. OKM1 positivity was observed in thes~ same 16cations with the 
exception tnat the staining was weaker in the dendritic and enduthelial cells 
of small capillary-sized vessels found in the portal tracts. 
Retransplanted Specimens 
The results of the clinicopathologic analysis are sho\·m in Table 2, and the 
scoring ~f each cell~lar subset identified ~ithin the tissue specimens using 
the monoclonal antibody panel utilized is shown in Table 3. Group A (cases 1-
10) consists of the cases which represent rejection and Group B (c3ses 11-20) 
had evidence of one or more etiologies other than rejection that could be, at 
least partially, responsible for the graft failure. It should be noted however, 
that coexistent rejection could not be ruled out in some of the cases in group B. 
T cells (T11+) co~prised the major population of infiltrative cells in 
the hepatic tissue of group A (sea table 3) and were most prominent in the 
portal tracts. qh~y were also present in the ce~trilobular regions Ecas~s 1-5) 
but were fewer in nu~oer in this location. These cells were often located 
im~ediately oenea~h the port31 and central vein endotheliu~I around and 
infiltrating the epithelium of small bile ductules (figures la-b). Formation 
of "tight cell clusters tt centered around bile ductules Was n:>ted in all cases 
in group A (figure 1c) and in some cases (11, 13, 15 and 19) from group B. T 
cells were also promin~nt in group B in a distribution similar to that s~en in 
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prevalent in group A specimens, making it difficult to identify s~all bile 
dUctules especially in cases 5, 7, 8, 9 and 10. 
The ratio of T4/T8 cells W3S approximately equal to or slightly greater 
than one in all the cases, except case 10, in which the number of T8 positive 
cells was much greater than that of T4 positive cells. Both of these 
lymphocyte subpopulations could be seen infiltrating the venous subendothelial 
space and the biliary epitheliu~ in the tissue speci~ans obtained fro~ patients 
in group A. 
B cells (B1+) ware more conspicuous in group A specimens, forming small 
nodules (figure 1c) in cases 6,7.9 and 10 in the portal tracts. In group B 
specirne~s no nodular aggregates of B1+ cells Were found, but the cells were 
located in the portal tracts. 
:'bnocytes/macropha3es dnd polymorphonuclear leukocytes (OKM 1 +) were 
prominent in several cases from group B (see Table 3), in ~hich there was 
evidence for bacterial cholangitis 31d/or coexistent viral infection. In 
group A tissues, OKM1+ cells were evident immediately adjacent to bile ductules 
and in the vascular SUbendothelial space but in fewer numbers than Were the T 
cells. However, they were conspicuous at the edge the limiting plate, 
infiltrating the periphery of the lobule. NK cells for:ned a minor proportion 
of the cellular infiltrdte in all the cases studied and had no apparent 
relationship to anatomic structures. 
In contrast to the norlodl control specimens, biliary epitheli!.J:n of both 
small interlobular and larger septal ducts. portal and oentral vein and hepatic 
artery endoth~lium (200 m internal diameter) stained with anti-DR/Ia in 
allograft livers. The positivi~y ~Op at times focal, in that it varied fro~ 
portdl t.ract to portal tract. In nost instances, when the biliary epitheliu!!l 
;;35 infiltrated by inf13:nr.13tory c~l1sI it ..las DR!Ia positive. It should be 
noted however, that positive staining in the af~re~entioned structures was seen 
in bot~ patient groups to varyinti de~rees (see Table 3). ao/f~ positive 
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infiltrating cells were not scorad d~e to reactivity of anti-DR/la monoclonal 
reagents on saveral mononuclear cell subsets. 
Correlation With Liver Injury Tests 
Bilirubin values varied widely and no significant difference between the 
t~o groups was apparent. However, in Group A patients the relationship of 
hepatocellular (SGOTlSGP'f) to bile ductular E~m/ddqmF enzy,nes Has indicative 
of a selective injury to the biliary epithelium (see table 2). Biliary tract 
patency was confirmed by cholangiography, or attested to by ultrasound or 
computerized axial tomography in 311 c~ses from Group A. No significant 
differences in medication regimens was noted between the two groups. Toe 
hepatocellular enzyme3 were markedly elevated in the serum of the patients in 
Group B in whom significant hep-3tocellular necrosis was apparent microscopically. 
DISCUSSION 
An attempt was made to segregate the cases in which the only apparent 
cause for graft dysfunction ani event~al failure was allograft rejection (Group 
A)"from thOSe in ~ich other ca~ses for graft failure were possible. It was 
recognized that when We c08pared the findings in group A to group 3 that th~ 
two groups differed wi~h respect to time post-transplant and incidence of 
primary disease, th~t selection based on allograft failure introduced bi~s and 
that some casas in Group B m3Y have had a co~ponent of rejection. However, the 
spectrum of primary disease in cases included in this study in general reflects 
that seen in this transplant popul~tionK Also, it is not uncom~on for patients 
with sclerosing cholangitis and biliary sepsis pretransplant to dev210p septi~ 
cholallgitis post-operatively (1). ~e are not suggesting therefore, t.hat all 
patients experiencing rejection ~ill fit the profile of the pPtien~s we stuJied 
in group A. 
Altnough T cells are the major subpopulation of infla~~atory cells present 
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significant proportion of th~ infiltrate. Thus, it is likely that several 
different immune mechanisms contribute to graft destruction as suggested by 
Hayry (5). In this respect, tha composition of the inflammatory infiltrate in 
group A specimens is not unique to rejection (4). eow~varI the localization of 
the infiltrate beneath the endothelium of veins and the formation of "tight 
clusters" of T11+ (Figure lb) and l~iD+ cells cent~red around, and infiltrating 
small bile ductules, suzgests that a selective im~unologically mediated 
reaction may be directed at these structures. This phenomenon may be relat2d 
to the differential expression of class I and II MHC antigens within the liver. 
The portal tracts normally contain an abundance of DR/Ia posi tive dendritic 
cells and small capillary-sized vascular endothelial cells, as shown in the 
control specimens used in this and other studies (6). Expression of class I 
and II (MHC) within the liver is normally more prominent on endothelial, 
reticuloenjothelial and biliary epithelial cells (class I predominantly), than 
it is on hepatocytes where it is either weak or absent (6.7.8). It appears 
that following transplantation. DR/Ia antigens become 2xpressed on venous 
endothelium. and focally on biliary epithelium and hep~tic artery endotheliu~K 
This adds greatly to the immunogenic potential of th~se structures (5.9). 
Consistent with this concept is the finding that morphologically. th~ 
structures expressing these DR/Ia anti3ens are preferentially involved in the 
rejection reaction (1,2,10). Porter was the first to document the swelling of 
the portal and central vein endoth~lial cells associated with s~bendothelial 
inflammatory cells in untreated animal allograft recipients (2). Follo· ... ing 
successful transplantation, Porter also docu~Ont~d the repl~~ement of 
sinusoid~l Kuppfer cells in hu~an allografts by host reticuloenjothelial cells 
(2). The above ob.3erva tions indicat~ tha t the preferential but not exclusive 
localization of th~ infla~~ation associated with rejecti~n to the portal tracts 
may be related to the presence and concentration of ~nti~en in those areas. 
Focal DRILl positivity in biliary epitheli81 cells has been reported 
re:-:ently in orlD~ or':h:':J;>ic hrD~D;Pn tr'3n3p13rt-d liver ("). 3,raft-','ersJ3-:1Jst 
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disease in experimental animals (12) and primary biliary cirrhosis (13). 
Importantly, bile ducts are destroyed in each of these disorders (1,10.14.15.16). 
It is interesting to note that GGTP is located in the biliary epithelial cells 
and in animal studies has been shown to be preferentially elevated when there 
is s~lective injury to bile ducts (17). ~e propose that the selective 
im,nunologically mediated destruction of biliary epithelium in rejection is 
manifest in patients by striking elevations of serum GJTP (18) in co~parison to 
serum hepatocellular enzymes. A similar hypothesis has been suggested in the 
pediatric liVer allograft recipients (19). 
It appears that the induced expression of DR/la antigens on biliary 
epithelium occurs to some de3ree in most if not all transplanted liver 
allografts as positive staining was seen in the tissue obtained fro~ patients 
in both groups. Whether this expr~ssion is a 'resul t of ongoin3 im::1unologic 
reaction with local production of lyrnphokines, circulating mediators i~volved 
in the alloreaction. or simply from cell da~PPe and re3eneration is uncertain. 
It has been emphasized. however. that the increased expression of DR/Ia 
antigens occurs in lesions involving activated lyrnphocytes (12). Although no 
clear cut difference with respect to DR/Ia antigen expression exists between 
these two groups, co~parison of rejection s~ecimens with post-transplant 
biospies in which there is no cOlilplicating pathology (unlike group B) may yield 
more informative data. Likewise. staining of liVer specimens for the presence 
of DR/la antigens removed secon,jary to toxic injury alone without immune 
mediated destruction may help determin~ whether lymphokines are involved in 
ind~cing the expression of these class II antigens on biliary epithelial cells. 
Thd significance of the inducible expression of DR/Ia antigens on 
structures tar 6ei:.ej for immmune destruction is oPen to smec~l~tionK It has 
been reported however. that both Class I and II histoco~patibility antigens are 
cap1ble of elicitin3 a cytolytic T-lympnocyte response and that Pnti~en density 
on the tdrS~t cell may be 3 factor in recognition (5.9). The 1llograft 
rCg~tion ~it~ i~f1P~~Pt~ry c~ll infiltration ~Py ~e tril~~rej by str~ct~res in 
-------------
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the portal tracts that normally ~xpress both class I and II MHC antigens. The 
initial event5 may then be follow~d by induced expression (via lymphokines?) of 
class II antizens on nearby structures m~king them more susceptible to immune 
recognition and destruction. Hall et al (20) reported the induced expression 
of DR antigens in the kidney tubular epithelial cells during rejection of renal 
transplants. He sugg~sted that 2xprassion of DR antigens may be important in 
enhancing the capacity of thase cells to be recognized by a delay~d-
hypersensitivity type rejection reaction. 
~KIre cannot co:nment on the reversibility of ~o/ra expression wi~h treat:nent 
of rejection as no samples from th2 sarna patient were axamined sequentially. 
Navertheless, interruption of the processes associataj with DR/la antigen 
expression on bile ducts may enhance graft survival, since destruction of th~se 
cells appears to be a significant contributing factor in graft failure. 
The li~itations of a~ in-situ analysis of infla~matory infiltrates using 
monoclonal antibodies in renal transplantation biopsy spOci~ens has been 
recently outlined by Hancock (21). They include th~ specificity of the 
antibody-antigen reaction, distribution and alteration of antigen expression in 
mo~onuclear cells depending on their maturity or activity, and the correlation 
of the phenotype with the functional properties of the cell. qh~se particular 
limitations also apply to our study. Nevertheless, we feel that the 
information gained from this in-situ 3nalysis offers an insight into at least 
so~c of the i~munogenetic mecnanis~s potentially associated with the initiation 
and/or maintainance of hepatic rejection. 
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D.G. Sheahan for helpful advice and ~rsK Mary h~ssler for preparation of the 
!:H n'lS::: r ipt. 
---- _._-----------
-11- Oemetris et al 
REFERENCES 
1. Demetris AJ, Lasky S, Van Thiel DH, Starzl T£, Dekker A. Pathology of 
Hepatic ~ransplantation: A review of 62 adult allograft recipients 
immunosuppress~d with a cylcosporine steroid regimen. ~~K J. Pathol. 
118:151-161, 1985.· 
2. Porter KA: Patholosy of liver transplant3tion. Transplant Rev 2: 129-170, 
1969. 
3. :-4cLean IW 3!'ld NClk:iOe PK: meriodate-lysine-parafor:~aldehyde fixative. A 
; 
ne'rl fixativa for i:nrIunoele~tron microscopy. J Histochem Cytochem 22: 1077-
1083, 1974. 
~K Si L, Whiteside TL, Schade RR, Starzl TE, Van Thiel DH: Studies of 
lymphocyte 3uubsets in liver tissue of pati~nts with primary biliary 
cirrhosis (PSC), primary sclerosing cholanaitis (PSC) and normal controls. 
J Clin Immunol 4:262-272, 1984. 
5. H3yry P: Intragraft events in allograft destruction. Transplantation 38:1-
6, 1984. 
6. D.:::ar AS. Fuggle SV, Fabre Jvl, Ting A, Horis PJ: T:1e detailed distribution 
of MrlC class II antigens in normal hUD3n organs. Transpla!'ltation 38:293-
298, 1984. 
---.-.. ----------
-12- Demetris et al 
7. Daar S, Fuggle SV, Fabre .r .... , Ting A, Horris PJ: The detailed distribution 
of HLA-A,B,C, antigens in normal hUman organs. Transplantation 38:281-292, 
1984. 
8. iautens~hlag~r I, Hayry P: Expression of the major histocompatability 
complex antigens on different liver cellular components In rat and man. 
Scand J Immunol 14:421-426, 1981. 
9. Burakoff SJ, ~einberger 0, hrens~y AM, Reiss CS. A molecular analysis of 
the cytolytic T-lymphQcyte response. Adv. Immunol. 36, 45-85, 1984. 
10. Fennell RH: Ductular da~age in liver transplantation. Pathol Ann 16:289-
294, 1981. 
11. Tak3s L, SZ2nde B, Honostori E, Rot A, L3pis K, Szecsey A, lndo I: 
Expression of ~i~-ao antig~ns on bile duct cells of rejected liver 
transplants (corres). Lancet 1I:1500, 1983. 
12. SJitters AJ, Lalnpert IA: C13ss II ant.igen induction in the liver of rats 
with graft-versus-host disedse. Transp13ntation 38: 194-196, 1984. 
13. Ballardini G, Mirakian R, Bianchi FB, Pisi E, Doniach D, Bottazzo GF: 
Aberrant expression of HLA-DR a~tigens on bile duct epitheliu~ in primary 
biliary cirrhosis: Relt!vance to p3thogencsis. Lancet II: 1009-1013. 1984. 
------------ D-DK-~K-K-- --~--~~ ---_._--------
-13- Oemetris et al 
14. Wight DGD: Pathology of rejection, Liver Transplantation: The 
Cambridge/King's College Hospital ExperiencQ. Edited by RY CaIne, New 
York, Grune and Stratton, 1983, pp. 247-277. 
15. Scheuer PJ. Primary biliary cirrhosis: Diagnosis, pathology and 
patho3enesis. Postgrad. Med. J. 59: 106-115,1983. 
16. Shulman HM, Sullivan KM, Weiden PL: Chronic graft-versus-host syndrome in 
IT.an: A long-term clinicopathologic study of 20 Seattle patients. Am J Med 
69:204-217. 1980. 
17. Leonard IS, Neptun DA. Popp JA: Serum ga'nma glutar'lyl transferase as a 
specific indicator of bile du::::t lesions in the r3t liver. Arn J Pathol 
116:262-269, 1984. 
18. Lasky S, DeC!letris AJ, Dek!<er A, Gav3ler JS, ~~hiteside T, Van Thiel DH: 
df~tamyl transpeptid~se (GGT): A marl{er for rejection following liver 
transplantation. Hepatology 4: 1045, 1984 (abstract). 
19. Pi~onsen R, Virji MA: Interpreting the profile of liver-function tests in 
pediatric liver transplants. Clin Chern 30:1607-1610, 1984. 
20. Hall B~I Bishop GA, Dug3in GG, Horvath JS, Philips J, Tiller DJ: Increased 
ex?ression of HLA-DR antigens on renal tubular cells in renal transplants: 
Relevance t~ th~ rejection response. Lancet II 247-251, 1984. 
21. ~ncoc~ ~i: Analysis of intragraft eff~ctor mechanisms associated with 
hr~Pn ren3l allograft rejection: fm~unohistologicPl stu1ies with 
m::>noclonal antiboKji~sK I:nllunological Rev 11:61-84. 1984. 
-14- Demetri s et a 1 
22. Hine CH, Pasi A, Stephens BG: F3talities following exposure to 2-
nitropropane. J Occup Med 20: 333-331, 1918. 
-15- Ce~etris et aJ 
Table 1 - Listing and Specificity of Monoclonal Antibodies Used 
Monoclonal Ab 
T 11 
T4 
T8 
OKH1 
JKM5 
81 
12(Ia)/DR 
Leu 7(NK) 
Antibody Specificity 
Total T cells 
T helper/inducer subset. 
T suppressor/cytotoxic s~bs~t 
Honocytes, Some endothelial cells, granulocytes 
Adherent monocytes, platelets, some endo-
thelial cells 
B lymphocytes 
A~tlvated T cells, B cells, 
monocyte/macrophage, cells expressing 
class II MHC antigens 
Natural killer cells, null cells 
* cross-reacteJ in so~e CPp~p ~ith sinusoidal ~ells in liver 
-------------, 
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Table 2 - Clinicopathologic D3ta from Liver Allograft P3tients 
CASE AGEl ORIGINAL TIME 
SEX DISEASE POST-
TX. 
(DAYS) 
"CLINICOPATHOLOGIC 
INTERPRETATION· 
(LABORATORY VALUES)x 
BIL SGOT SGPT AP GGTP 
(T/O) 
mg/dl U/ml U/ml rU/L rU/L 
1 
2 
3 
4 
5 
6 
1+ 
8 
9 
10 
25/F 
42/F 
51/F' 
23/F 
44/F 
44/F 
44/1" 
22/F 
19/F 
32/M 
CAH 
PSC 
PBC 
CAH 
PSC 
PBC 
PI3C 
o 2 BC 
CArl 
CHF 
11 o 25/M Toxin 
12 39/rl 
13 32/M 
14 29/H 
15 PO/1~ 
16 21/F 
17 39/F 
1 a 26/1-1 
19 45/:-1 
20 PO/r~ 
SC 
SC 
SC 
SC 
CAH 
PSC 
SC 
SC 
SC 
Abbreviations: 
8 
18 
30 
41 
70 
93 
150 
240 
2190 
>4380 
8 
Rejection 
Rejection 
Rejection 
Rejection 
Rejection 
Rejection 
Rejection 
Rej.:ction 
Rejection 
Rejection 
? circu13tin$ toxin 
renal failure 
9.8/6.6 
19.4/13.6 
39.6/33 
28.2/13.4 
19.8112.1 
27.0/21.0 
15.2/10.1 
10.2/1.6 
20/16.8 
5.5/3.0 
27.2/22 
hypotension/cholangitis 
130 
70 
65 
85 
563 
412 
210 
121 
307 
124 
607 
112 
337 
153 
46 
1044 
552 
274 
177 
241 
98 
369 
44 
715 
579 
990 
956 
1008 
896 
990 
1365 
792 
NA 
66 
2360 
1134 
708 
1641 
>3000 
803 
1455 
1045 
2660 
221 
8 poor graft 18.6/15.2 70 346 80 67 
preservation 
10 Klebsiella sepsis/ 3.711.6 1216 1530 118 32 
bacterial cholangitis 
14 biliary tract 31.8(24 4116 3969 122 82 
obstruction 
19 MI xO/pepis/~raft 15.0/12.7 3240 4590 498 NA 
ischemic 
19 Hepa tic artery 8.8/5.3' 35 379 136 163 
thrombosis/gr3ft 
ischemia 
22 Coagulopathy/Renal 25.8/19.8 139 199 319 320 
failure/cyclosporine 
)2000 mg/ml 
40 Treated Rejection 5.2/4.1 5479 1655 154 119 
and CHV 
111 Sepsis/Rejection 22.4/18.4 81 27 86 156 
and CMV 
48 Treated Rejection 
and CHV 
5.1/4.1 972 665 
CAH = Chronic active hepatitis (etiology uncertain) 
PBC = Primary biliary cirrhosis 
20 BC = Secondary biliar¥ cirrhosis 
CHF = Congenital hepatlc fibrosis 
SC = Sclerosing cholangitis 
C~s = Cytomegalovirus Hepatitis 
In = Myocardial infarction 
Nl = Not available 
81 60 
.) Pertinent negdtives in cases 1-10: biliary tract anj blood vessel patency. 
hepatitis serolo~iesK blood and bile cultures (when av~ilableFK 
x Bilirubin (Total/Direct). serum gluta~ate oxalo3cetic transaminase (SGOT). 
serllro glut3::Jat"e pyr\..lvate transaminase (.3GPT). alkaline phosphatase (AP) 
Pa~~a gluta::Jyl transp~ptidase (GG!P). 
+ case 7 is th~ second failed allogrdft from patient in case 5. 
o q~xin Exposure (2-Nitropropane) (22). 
Case No. 
1 
2 
3 
" 5 
6 
7 
8 
9 
10 
11 
12 
t3 
14 
15 
16 
17 
18 
19 
20 
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Table 3 - An31ysis of Inflammatory Cell SubsetsO 
in Failed Allograft ppe~imens 
Demetris et al 
Portal Infiltrate DRlIa 0 Stain in&, 
T cel1s B cel1s Monocyte/macrophage 
(T 11) (B1) polys (OKH 1) BDE HAE PVE 
3 1 2 4 3 3 
3+ 2 2 
" 
3+ 3 
2+ 1 2 2+ 2+ 3 
3+ 1 1 3+ 4 3+ 
2+ 1 + • 3 
" 3+ 2 2 * 2+ 3 3 2 1 * 3 2+ 
1+ +/- +/- 2 2 
3+ 2 1 * +/- +/-3+ 2 1+ * 1 1 
1+ +/- 2+ 1 +/- 1 
1 +/- 2+ +/- +/- 1 
3 1+ 
" 
• 3 3 
3 1+ 4 2 1+ 3 
1+ 1 1+ 2+ 3 3 
2+ +/- 1 3 2+ 3 
+/- 0 0 0 0 +/-
2 +/- 2+ 4 2+ 3 
3 1+ 1+ +/- 1+ 1+ 
3 2 2+ 2+ 2 3 
Abbrevatio;'ls: BDE = bile duct epith~lium 
HAE = hepatic artery endothelium 
PVE = portal vein endotheliu~ 
* rne bile ductules were decreas~d in number and/or obsc~red by inflammation 
making scoring difficult. 
0 3.=e Materials and :"ethods 
+/- Slightly greater than control tissue 
-----"-"------
-13- Demetris et al 
Figure Legends 
1a) T lymphocytes (Tl1+) in the portal tract frolD casa 1. Note the cells 
beneath the portal vein (PV) endothelium (large arrowhead) surrounding 
bile ductules (arrow) and relative restriction of Tl1+ cells to the portal 
tracts (T 11 IPEX, hematoxylin, 125x). 
lb) Higher power (SOOx) of the above specimen showing T cells adjacent to 
and infiltrating a small bile ductule sectioned longitudinally (outlined 
by 3rrolols). 
lc) T cell lymphocytes (T11+) in liver tissue from case 4 showing "tight 
cl~stering" of inflammatory cells surrounding a small bile ductule (arrow, 250x). 
ld) Liver tissua from case 2 stainej for 1a antigen, sho~ing positivity in 
larger septal ~ile duct (BO), ~ndotheliun of hep3tic artery (HAt 
arrowhe3d) and small bile ductul~s (arrows), which are surrounded by 
inflanm3tory cells (125x). 
la) B lymphocyte (Bl+) in a portal tract from case 1 showing a "nodule of B 
cells". Bile dUctules could not be s~en in this portal tract (315x). 
<315x) • 
If) OKM1+ cells in tissue from case 13 showing numerous positive cells 
in the port3l tracts. This casa was complicated by sepsis and bacterial 
cholangitis (125x). 
